HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 66,082 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers          << Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>   New CDRH Tool for ’Scope Reprocessing Assurance [543 Words] [ Price : $8.95] CDRH scientists and engineers develop a new tool to help hospitals determine how clean an endoscope is after it has been reprocessed. 01/09/2020     Info Collection on Administrative Practice/Procedures [79 Words] [ Price : $8.95] Federal Register notice: FDA seeks comments on an information collection revision for “General Administrative Practice and Procedures.” 01/09/2020     Much of Higher Drug Spending Not Going to Companies: PhRMA [2706 Words] [ Price : $8.95] A PhRMA-funded study says drug companies are not retaining much of the increased drug spending in the U.S. 01/09/2020     Penumbra Expanded Indication for Aspiration Device [86 Words] [ Price : $8.95] FDA clears a Penumbra 510(k) for an expanded indication for its Indigo Aspiration System — treating pulmonary embolisms. 01/09/2020     Public Meeting on Modernizing FDA Data Strategy [71 Words] [ Price : $8.95] Federal Register notice: FDA announces a 3/27 public meeting entitled “Modernizing FDA’s Data Strategy.” 01/08/2020     Comments Extended on Certificates of Confidentiality Guide [135 Words] [ Price : $8.95] Federal Register notice: FDA extends until 1/24 the comment period for a draft guidance entitled “Certificates of Confidentiality; Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff.” 01/08/2020     FDA Focus Group Info Collection Extension [136 Words] [ Price : $8.95] Federal Register notice: FDA seeks comments on an information collection extension on “Focus Groups as Used by the Food and Drug Administration (All FDA-Regulated Products).” 01/08/2020     Comments Extended on Homeopathic Drug Guide [81 Words] [ Price : $8.95] Federal Register notice: FDA extends until 3/23 the comment period on a revised draft guidance entitled “Drug Products Labeled as Homeopathic.” 01/08/2020     Blueprint Rolling NDA for Lung Cancer Drug [160 Words] [ Price : $8.95] Blueprint Medicines begins a rolling NDA submission for pralsetinib after reporting top-line data from a pralsetinib study in patients with RET fusion-positive non-small cell lung cancer. 01/08/2020     Quality by Design Advantages Explained [2683 Words] [ Price : $8.95] Recipharm staffers discuss the advantages of a quality by design approach to drug manufacturing. 01/08/2020     << Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com